Natick, MA · Founded 2014 · Privately Held (backing)
Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care. Pillar Biosciences is based in Natick, MA and was founded in 2014. It was valued at $309 million at its later-stage round in May 2025, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $20 million early-stage round in May 2021.
PMV mark · valuation
$309.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$120.9M
Last round
Early Stage VC
May 2021
Cap table — not yet on record
Pillar Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pillar Biosciences with a free account
·Watch Pillar Biosciences: the Monday email on marks, rounds and moves
Where does Pillar Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pillar Biosciences's 2 recorded funding rounds.
